Farmacopeia Inc., a female focused medical cannabis health and wellness company, has closed a new round of financing, raising $[mepr-active rule=”374″ ifallowed=”hide”]#SUBSCRIBERS ONLY CONTENT Where and how did you get your news? Subscribe today to see our research on this and all other subscriber ONLY news. See what you have been missing and be informed!#[/mepr-active][mepr-active rule=”374″]2.662 million from 37 Ontario, Alberta, Barbados and USA investors. Norton Rose Fulbright Canada LLP acted as legal counsel.
Farmacopeia board is comprised of Paul Amirault (Director), Hugh Bowman (Director & COO), Renée Ellison (Director & founder), and Justin Shimoon (Chairman).[/mepr-active]
Farmacopeia previously announced the closing of a $3.5 million private placement. Michael Smith, a substantial participant in the private placement, joined company as Chief Executive Officer. Smith is formerly founder/CEO of CIM and CEO of Launch Brand Marketing.
Farmacopeia was founded by Renée Ellison in 2013.
photo credit: Farmacopeia